Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
Satoshi Inoue(Institute for Advanced Medical Research), Julia Y. Ljubimova(Cedars-Sinai Medical Center)
Cited by 55
Related Papers
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
|Nature Communications|2019|290
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
|Nature Communications|2019|137